Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Food and Drug Administration Grants
Food and Drug Administration
The purpose of this funding opportunity announcement (FOA) is to support clinical studies of products that address unmet needs in rare diseases or conditions or provide highly significant...morePosted On - 2018-10-23
Food and Drug Administration
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare...morePosted On - 2018-10-12
Food and Drug Administration
This program expansion FOA provides a mechanism for organizations receiving only Competition A funding under PAR-16-137 to apply for Competition B funding. Only those states/territories currently...morePosted On - 2018-10-09
Food and Drug Administration
Purpose FDA is seeking information submissions from the public. Information is being solicited to inform planned work to promote development of publicly available standard core sets of Clinical...morePosted On - 2018-07-31
Food and Drug Administration
The Food & Drug Administration’s (FDA) Center for Veterinary Medicine’s (CVM) Office of Minor Use & Minor Species Animal Drug Development (OMUMS) was created after “The...morePosted On - 2018-06-12
Food and Drug Administration
The Cooperative Agreement will build upon the extensive experience of an institution with well-established and globally recognized collaboration with inspectorates of National Regulatory Authorities...morePosted On - 2018-06-11
Food and Drug Administration
Background Mechanism-based physiologically based pharmacokinetic (PBPK) models have been proven to be powerful tools in the generic drug development process and bioequivalence assessment. Major...morePosted On - 2018-05-23
Food and Drug Administration
RESEARCH OBJECTIVES The FDA Center for Drug Evaluation and Research seeks to support efforts to research, identify key issues, and convene appropriate subject matter experts to help advance...morePosted On - 2018-05-17
Food and Drug Administration
The Cooperative Agreement announced in this FOA represents the continuation and further refinement as well as expansion of well-established collaborations between WHO and FDA, through OIP, in support...morePosted On - 2018-04-25
